Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Prostate cancer
Closed
Phase 2
This trial is looking at docetaxel and saracatinib for prostate cancer that has continued to grow despite other treatment and has spread outside the prostate. This trial is supported by Cancer Research UK.
Recruitment start: 16 October 2013
Recruitment end: 30 April 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Rob J Jones
AstraZeneca
Beatson Oncology Centre
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NHS Greater Glasgow and Clyde
NIHR Clinical Research Network: Cancer
University of Glasgow
This is Cancer Research UK trial number CRUKE/10/043.
Last reviewed: 29 April 2016
CRUK internal database number: 6192